Line 79: | Line 79: | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure hundred" src=" | + | <img class="figure hundred" src=""> |
<figcaption> | <figcaption> | ||
<b>Figure 1:</b> Ferritin is suitable for metal recycling, since it can form e.g. iron, silver and gold nanoparticles in its cavity. | <b>Figure 1:</b> Ferritin is suitable for metal recycling, since it can form e.g. iron, silver and gold nanoparticles in its cavity. | ||
Line 96: | Line 96: | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure hundred" src=" | + | <img class="figure hundred" src=""> |
<figcaption> | <figcaption> | ||
<b>Figure 2:</b> Alignment of the protein sequences of the wild-type and the mutated human ferritin heavy chain. The Alignment was produced with Clustal Omega (Goujon et al., 2010, Sievers et al., 2011). | <b>Figure 2:</b> Alignment of the protein sequences of the wild-type and the mutated human ferritin heavy chain. The Alignment was produced with Clustal Omega (Goujon et al., 2010, Sievers et al., 2011). | ||
Line 107: | Line 107: | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure hundred" src=" | + | <img class="figure hundred" src=""> |
<figcaption> | <figcaption> | ||
<b>Figure 3:</b> Protein structures of the wild-type human ferritin (<b>A</b>, RCSB ID 4oYN) and the mutated human ferritin (<b>B</b>, RCSB ID 3ES3). Despite the mutations of ten amino acids the ferritin retains its shape. The protein structeres were generated with Chimera (Pettersen et al., 2004). | <b>Figure 3:</b> Protein structures of the wild-type human ferritin (<b>A</b>, RCSB ID 4oYN) and the mutated human ferritin (<b>B</b>, RCSB ID 3ES3). Despite the mutations of ten amino acids the ferritin retains its shape. The protein structeres were generated with Chimera (Pettersen et al., 2004). | ||
Line 121: | Line 121: | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure hundred" src=" | + | <img class="figure hundred" src=""> |
<figcaption> | <figcaption> | ||
<b>Figure 4:</b> Possible applications of nanoparticles produced with ferritin. | <b>Figure 4:</b> Possible applications of nanoparticles produced with ferritin. | ||
Line 136: | Line 136: | ||
<b>Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.</b> </br> | <b>Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.</b> </br> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</div> | </div> |
Revision as of 09:40, 16 October 2018
Part Collection
Short Summary
Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.
Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.